Temidayo Fadelu, MD, a postdoctoral fellow at Dana-Farber Cancer Institute, Boston. He led a seven-year study of 826 Stage 3 colon-cancer patients, scheduled for presentation at the annual meeting of the American Society of Clinical Oncology, Chicago.
No Recent Articles
